Compliance to advocated therapeutics in and head and neck oncosurgery clinic in a tertiary health care facility in North India: a pilot study

Manish Munjal, Japneet Kaur, Nitika Tuli, Porshia Rishi, Harjinder Sidhu, Shubham Munjal


Background: Head and neck neoplasms are the tumours of head and neck region including various subsites in oropharynx, nasopharynx, larynx, upper oesophagus, paranaal sinuses, and ear. Various treatment modalities are available depending on the stage, type, site of tumour. This study was conducted to study the compliance of patients diagnosed with various head and neck neoplasms towards recommended treatment modalities.

Methods: 243 patients presenting in the outpatient department of a tertiary care hospital in Northern India with positive biopsy for neoplastic pathology, benign and malignant were included in the study for a period of 2 years (January 2018-December 2019). All the patients were counselled and those who complied with the suggested therapeutic modality were further evaluated.

Results: Surgical intervention was carried out in 79 subjects with benign and 133 with malignant pathologies. 49 patients among 133 were advised further surgical intervention. 31 patients underwent second surgery. Radio-therapeutic and chemotherapeutic modalities were undertaken in 66 subjects. 39 patients did not comply with treatment and were lost to follow up.

Conclusions: Decision making for head and neck neoplasms is extremely important and should be considered after thorough discussion with the patient.


Compliance, Head and neck cancer, Tumour

Full Text:



Semple C, Parahoo K, Norman A, McCaughan E, Humphris G, Mills M. Psychosocial interventions for patients with head and neck cancer. Cochrane Database Syst Rev. 2013;7:CD009441.

Dronkers EAC, Mes SW, Wieringa MH. Noncompliance to guidelines in head and neck cancer treatment; associated factors for both patient and physician. BMC Cancer. 2015;15:515.

Derks W, Leeuw JR, Hordijk GJ, Winnubst JA. Reasons for non-standard treatment in elderly patients with advanced head and neck cancer. Eur Arch Otorhinolaryngol. 2005;262:21-6.

Joseph K, Vrouwe S, Kamruzzaman A, Balbaid A, Fenton D, Berendt R, et al. Outcome analysis of breast cancer patients who declined evidence-based treatment. World J Surg Oncol. 2012;10:118.

Lewis CM, Hessel AC, Roberts DB. Prereferral head and neck cancer treatment: compliance with national comprehensive cancer network treatment guidelines. Arch Otolaryngol Head Neck Surg. 2010;136(12):1205-11.

Kusaba R, Sakamoto K, Mori K, Umeno T, Nakashima T. Laboratory data and treatment outcomes of head and neck tumor patients in the elderly. Auris Nasus Larynx. 2001;28:161-8.

Sanabria A, Carvalho AL, Vartanian JG, Magrin J, Ikeda MK, Kowalski LP. Factors that influence treatment decision in older patients with resectable head and neck cancer. Laryngoscope. 2007;117:835-40.